Technivie (ombitasvir, paritaprevir and ritonavir)

  • Pharmacy Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: Jay W. Marks, MD
    Jay W. Marks, MD

    Jay W. Marks, MD

    Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.

GENERIC NAME: ombitasvir, paritaprevir and ritonavir

BRAND NAME: Technivie

DRUG CLASS AND MECHANISM: Technivie is a combination oral medication containing ombitasvir, paritaprevir, and ritonavir. Technivie is used with ribavirin (Rebetol) to treat genotype 4 hepatitis C virus (HCV) infections in patients without liver cirrhosis. Technivie belongs to a class of drugs called direct-acting antiviral agents. Similar drugs include

Ombitasvir and paritaprevir are antivirals that have direct activity against HCV. They block the effect of proteases which are enzymes that HCV uses for making new viruses, leading to reduced numbers of HCV copies in the body. Ombitasvir blocks HCV NS5A protease while paritaprevir blocks HCV NS3/4A protease. The third medicine in Technivie, ritonavir, is not active against the HCV virus. It is used to increase blood levels of paritaprevir by inhibiting the breakdown of paritaprevir.

The combination of Technivie and ribavirin for 12 weeks resulted in 100% cure rates in patients with genotype 4 chronic HCV without cirrhosis. Cure was defined as undetectable levels of HCV in the body 3 months after treatment had ended. The FDA approved Technivie in July 2015.

PRESCRIBED FOR: Technivie is used in combination with ribavirin to treat adults with chronic HCV genotype 4 infection who have not developed cirrhosis.

Medically Reviewed by a Doctor on 8/14/2015

Quick GuideHepatitis C (Hep C) Symptoms and Treatment

Hepatitis C (Hep C) Symptoms and Treatment
FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

RxList Logo

Need help identifying pills and medications?

Use the pill identifier tool on RxList.

Subscribe to MedicineNet's Newsletters

Get the latest health and medical information delivered direct to your inbox!

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors